Raltegravir(1100750-83-1)
- Name: Raltegravir
- Synonyms:N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- Molecular Formula:C20H18D3FN6O5
- Molecular Weight:444.4163
- CAS Registry Number:1100750-83-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1100750-83-1 Raltegravir
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Transportation:Sea/air/courier Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] 
Premium
SupplierTel:+86-571-87396432
Address:No.200 Zhenhua Rd.Xihu Industrial Park, Hangzhou 310030, China
- Contact Suppliers
Other Product
- 859783-60-1/5-ethyl-2,4-dimethylaniline
- 1180132-17-5/5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-amine
- 1206228-65-0/3-Morpholinecarboxylic acid, 3-methyl-, methyl ester
- 868604-76-6/Tricyclo[3.3.1.13,7]decane-1-carboxylic acid, 4-[[2-methyl-1-oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl]pro pyl]amino]-, stereoisomer
- 868604-86-8/2-Methyl-2-(4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)propanoic acid
- 1380112-36-6/4-Thiazoleacetic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-α-[[[1-[(1,1-dimethylethoxy)carbonyl]cyclobutyl]oxy]imino]-, (αZ)-
- 1251908-67-4/1H-Indole-7-carboxylic acid, 5-(trifluoromethyl)-, ethyl ester
- 1196047-84-3/Ethyl 5-(trifluoromethyl)-1H-indole-7-carboxylate
- 1227266-80-9/(4-Methoxypiperidin-4-yl)methanol hydrochloride
- 857651-06-0/4-hydroxy-4-(5-(pyrimidin-2-yl)pyridine-2-yl) cyclohexanone
- 857651-01-5/Benzamide, N-[2-[(3S)-3-amino-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-, hydrochloride (1:1)
- 635318-04-6/(1S,2S,5R,6R)-di-tert-butyl 2-(tert-butoxycarbonyl)-4-oxobicyclo[3.1.0]hexane-2,6-dicarboxylate
- 1001180-45-5/1-Piperazinecarboxylic acid, 4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-, 1,1-dimethylethyl ester
- 1259393-33-3/(S)-7.9-dimethyl-N-(2-methyl-2H-tetrazol-5-yl)-2.3.4.5-tetrahydro-1H-benzo[b]azepin-5-amine
- 308062-09-1/N,N-Dimethyl (octan/decan)amides
- 336615-45-3/Bis(2-bromobenzyl)amine hydrochloride
- 1178560-67-2/1,2,4-Triazolo[4,3-a]pyridine, 6-bromo-3-[2-[[2-[[tris(1-methylethyl)silyl]oxy]ethyl]thio]phenyl]-
- 859217-05-3/Bafetinib
- 1156542-80-1/Benzenemethanamine, N-[2-methoxy-1-(methoxymethyl)ethyl]-N-(phenylmethyl)-
- 1100750-83-1/Raltegravir
- 1391054-37-7/1-cyclopropyl-2-(2-fluorophenyl)ethane-1,2-dione
- 261523-39-1/2-Oxetanone, 3-hexyl-4-(2-hydroxytridecyl)-, (3S,4S)-
- 120256-13-5/3-aminopyridin-4-ol hydrochloride
- 75535-11-4/Magnesium(2+), hexaaqua-, diiodide, (OC-6-11)-
- 1190100-18-5/Indeno[1,2-b]carbazole, 5,11-dihydro-11,11-diphenyl-
- 1233200-52-6/1,3,5-Triazine, 2-(9,9'-spirobi[9H-fluoren]-2-yl)-4,6-bis([1,1':3',1''-terphenyl]-5'-yl)
- 1207176-84-8/1,3,5-Triazine, 2,4-diphenyl-6-(9,9'-spirobi[9H-fluoren]-2-yl)-
- 960316-16-9/(3S,4S)-Tert-butyl 3-methoxy-4-(methylamino)pyrrolidine-1-carboxylate
- 866396-34-1/1-[[[(1-HYDROXYMETHYL)CYCLOPENTYL]AMINO]ACETYL]-2,5-CIS-PYRROLIDINEDICARBONITRILE HYDROCHLORIDE
- 381248-06-2/5'-broMo-1'-phenyl-[2,3'-bipyridin]-6'(1'H)-one